Q1 2026 Management view Exponent reported Q1 growth tied to AI-related client work and a mix shift across proactive and reactive engagements. Dr. Catherine Corrigan (President, CEO & Director) said, ...
Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. “Exponent delivered double-digit growth in revenues and earnings during ...
StockStory.org on MSN
Exponent (NASDAQ:EXPO) beats expectations in strong Q1 CY2026
Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2026, with sales up 21% year on year to $166.3 million.
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. “We delivered a strong ...
Exponent (NASDAQ:EXPO) reported double-digit growth in first-quarter fiscal 2026 net revenues and earnings, pointing to ...
Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares ...
Exponent is a business that we have admired from the sidelines for a while, and we finally saw an opportunity to initiate a position at an attractive price due to a rare pause in annual growth. No ...
Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. "Exponent delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results